The new initiative will allow candidate Ebola treatments to be assessed rapidly in patients, so that those proving safe and effective may be adopted for use as soon as possible.
A £3.2 million grant from the Wellcome Trust will enable multiple partners around the world to quickly establish clinical trials at existing Ebola treatment centres.